| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3882932 | Kidney International | 2013 | 4 Pages |
Abstract
Assessment of acute kidney biomarkers against changes in plasma creatinine is beset by issues of heterogeneity of study cohorts and timing of sampling. Siew and colleagues attempt to minimize these issues in a case–control study of three biomarkers in the intensive care unit. The results highlight the inherent methodological difficulties and the need to reference structural injury biomarkers against more meaningful outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Zoltán H. Endre, John W. Pickering,